6 July 2026
Getty/MJ_PrototypeBy Storm Newton, PA
Pharmacies are “bracing themselves” for a surge in patients starting weight loss drugs as the Wegovy pill becomes available.
Pharmacists also warned the new form of semaglutide could lead to a rise in fake or unlicensed weight loss pills being sold on the black market.
The Wegovy tablet, made by Novo Nordisk, became the first GLP-1 pill for weight loss to be approved by the UK’s medicines regulator last month.
The starting dose is 1.5mg, rising to 4mg, 9mg and 25mg – with patients required to be on each dose level for at least a month before going up.
From Monday, the lowest doses – 1.5 mg and 4mg – will be available as part of weight management programmes in some pharmacies to eligible patients.
However, a survey of 310 pharmacies by the National Pharmacy Association (NPA) found 76% expect to start a significant number of new eligible patients on the pill in the coming months.